Connection

William Groh to Sodium Channel Blockers

This is a "connection" page, showing publications William Groh has written about Sodium Channel Blockers.
Connection Strength

0.681
  1. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology. 2011 Jan 25; 76(4):409; author reply 409.
    View in: PubMed
    Score: 0.355
  2. Arrhythmia exacerbation after sodium channel blockade in myotonic dystrophy type 1. Muscle Nerve. 2009 Nov; 40(5):901-2.
    View in: PubMed
    Score: 0.326
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.